Nature Reviews Drug Discovery· Andreas Bender, Morgan C. Thomas, Jack W. Scannell, David A. Shaywitz, Gian Marco Ghiandoni, Joe G. Greener, Lavinia-Lorena Pruteanu, Rachel DeVay Jacobson, Koichi Handa, Mariko Hirano, Srijit Seal, Manas Mahale, Marco F. Schmidt, Tim Ahfeldt, Francesca Grisoni, Isidro Cortes-Ciriano·· 2026-08-07精选AI 评分58
Nature Reviews Drug Discovery观点文章：AI药物发现的现状与前进路径
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
AI 导读
【摘要级】Andreas Bender等人在Nature Reviews Drug Discovery发表观点文章，指出尽管AI方法在药物发现中被大量开发、应用和基准测试，其临床相关影响的证据迄今仍有限。
推荐理由
该观点文章梳理AI药物发现的进展与落差，并解释临床转化不足的可能原因，为评估该领域提供参照。
来源：Nature Reviews Drug Discovery · doi.org